Navin Robert Pinto, MD

Cancer and Blood Disorders Center, Neuroblastoma Program, Bone Tumors and Soft Tissue Tumors

On staff since November 2015

Children's Title: Principal Investigator

Academic Title: Associate Professor, University of Washington

Research Center: Center for Clinical and Translational Research

  • Navin Pinto, MD is an attending physician at Seattle Children's Hospital and an Associate Professor of Pediatrics at the University of Washington School of Medicine. Dr. Pinto is the Outpatient Medical Director for the Cancer and Blood Disorders Center.

    Dr. Navin Pintos has a longstanding interest in developing more targeted, less toxic therapies for children and young adults with cancer. He completed his fellowship and laboratory training at the University Chicago. Dr. Pinto is board certified in General Pediatrics, Pediatric Hematology/Oncology and Clinical Pharmacology. He has worked extensively in the field of cancer pharmacogenomics: using a patients genetic code to predict sensitivity to a given treatment regimen.

    In addition to his work in pharmacogenomics, Dr. Pinto is interested in bringing novel treatments to patients with relapsed or refractory solid tumors. He is involved in several Phase I trials at Seattle Childrens Hospital and works with collaborative groups locally, nationally and internationally to bring new treatments to the clinic. He is an active member of the Childrens Oncology Group (COG), the New Approaches to Neuroblastoma Therapy (NANT) and the Genomic Assessment Informing Novel Therapeutics (GAIN) consortia.

    Dr. Pinto is dedicated to offering hope to children with complex solid malignancies such as neuroblastoma and sarcoma by providing access to the most promising and innovative therapies.

    • Cherilyn Bothell 01.14.18

      With four cancer diagnoses in my immediate family we have encountered countless oncology and medical professionals. Dr. Pinto was our first oncologist and has remained my entire family's favorite medical professional. He is honest and forthcoming, yet sensitive and genuine. We never felt rushed and were always heard. Our son's treatment went exactly how he patiently explained it would. We are eternally grateful for Dr. Pinto.

    • Luciano SÃO PAULO/SP - BRAZIL 12.28.17

      We are having a great experience treating in Seattle with Dr. Pinto. He is a wonderful doctor, very atencious, and the most important he is fantastic human being.

  • Award Name Award Description Awarded By Award Date
    Scholar-In-Training Award American Association for Cancer Research 2011
    Young Investigator Award Cancer Research Foundation 2011 - 2015
    Loan Repayment Program National Insitutes of Health 2011 - 2016
    Young Investigator Award American Society of Clinical Oncology 2010
    Best Poster Presentation, Clinical Advances in Neuroblastoma Research 2010
    Teaching Fellow of the Year University of Chicago Department of Pediatrics 2009
    Senior Resident of the Year University of Chicago Department of Pediatrics 2008
    Intern of The Year University of Chicago Department of Pediatrics 2006
    Alpha Omega Alpha Medical Honors Society Saint Louis University School of Medicine 2005
    Rodney M. Coe Distinction in Community Service Saint Louis University School of Medicine 2005
    Summa Cum Laude Saint Louis University 2001
  • Other Publications

    • Darlington WS, Pinto N, Hecktman HM, Cohn SL, LaBelle JL
      Stem Cell Transplant-Associated Wernicke Encephalopathy in a Patient with High-Risk Neuroblastoma.
      26174546 Pediatric blood and cancer, 2015 Dec. : 62(12)2232-4
    • Pinto N, Hawkins DS
      Second Malignant Neoplasms in Rhabdomyosarcoma: Victims of Our Own Success or an Underlying Genetic Predisposition Syndrome?
      26505490 Pediatric blood and cancer, 2015 Oct. 27
    • Pinto NR, Applebaum MA, Volchenboum SL, Matthay KK, London WB, Ambros PF, Nakagawara A, Berthold F, Schleiermacher G, Park JR, Valteau-Couanet D, Pearson AD, Cohn SL
      Advances in Risk Classification and Treatment Strategies for Neuroblastoma.
      26304901 Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2015 Sept. 20 : 33(27)3008-17 PMCID:PMC4567703
    • Applebaum MA, Henderson TO, Lee SM, Pinto N, Volchenboum SL, Cohn SL
      Second malignancies in patients with neuroblastoma: the effects of risk-based therapy.
      25251613 Pediatric blood and cancer, 2015 Jan. : 62(1)128-33 PMCID:PMC4237647
    • Staley S, Hageman JR, Pinto N, Khan N
      An arresting sickle cell disease complication.
      24168124 Pediatric annals, 2013 Nov. : 42(11)448-51
    • Pinto N, Dolan ME
      Clinically relevant genetic variations in drug metabolizing enzymes.
      21453273 Current drug metabolism, 2011 June : 12(5)487-97 PMCID:PMC3110519

  • Presentations Title Event Location Date
    Integrating Cell-Based and clinical genome-wide studies to identify drug-specific mechanisms of treatment failure in neuroblastoma University of Chicago Department of Pediatrics Grand Rounds Chicago, IL 2013
    Relationship of divergent ancestral genetic variation on chromosome 6p22 and racial disparities in survival in neuroblastoma American Society of Clinical Oncology Chicago, IL 2012
    A Foot in Both Worlds, Caring for Children with Life-Threatening Illness Pediatric Palliative Care: State of the Practice Barrington, IL 2011
    Survival Variability by Race and Ethnicity in Neuroblastoma: A Children's Oncology Group Study Advances in Neuroblastoma Research Stockholm, Sweden 2010
  • Grant Title Grantor Amount Award Date
    Genomics of Treatment Failure in Neuroblastoma St. Baldrick's Foundation $445,000 July 1, 2012 - June 30, 2016


Board Certification(s)

Pediatric Hematology-Oncology

Medical/Professional School

Saint Louis University School of Medicine, St Louis


Pediatrics, University of Chicago, Chicago


Pediatric Hematology Oncology, University of Chicago, Chicago

Clinical Interests

Neuroblastoma, sarcoma

Research Focus Area

Cancer biology, Refractory and recurrent cancer, Sarcomas, Thyroid Cancer